U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

Results: 1 to 20 of 502

Tests names and labsConditionsGenes, analytes, and microbesMethods

ProstateNow

GoPath Diagnostics
United States
414
  • D Deletion/duplication analysis

Hereditary Prostate Cancer Panel

QDx Pathology Services, Inc.
United States
116
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Clariti 20/20

QDx Pathology Services, Inc.
United States
1544
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Prostate Cancer Panel

Clariti Diagnostics Laboratories LLC
United States
116
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Clariti 20/20

Clariti Diagnostics Laboratories LLC
United States
1544
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

OnkoRisk Hereditary Oncology Plus Panel

BioReference Health
United States
9777
  • C Sequence analysis of the entire coding region

OnkoRisk Hereditary Oncology Management Panel

BioReference Health
United States
4717
  • C Sequence analysis of the entire coding region

OnkoRisk Women's Hereditary Cancer Panel

BioReference Health
United States
3418
  • C Sequence analysis of the entire coding region

OnkoRisk Hereditary Urology Panel

BioReference Health
United States
2719
  • C Sequence analysis of the entire coding region

OnkoRisk BRCA Panel

BioReference Health
United States
42
  • C Sequence analysis of the entire coding region

Prolaris

Myriad Genetics, Inc.
United States
11
  • R RNA analysis

Precision GU

INTEGRATED MEDICAL PROFESSIONALS, PLLC
United States
210
  • T Targeted variant analysis

Invitae eMERGE Panel

Invitae
United States
5916
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

BRCA1, BRCA2

Centogene AG - the Rare Disease Company
Germany
112
  • C Sequence analysis of the entire coding region

BRCA1, BRCA2 Plus

Centogene AG - the Rare Disease Company
Germany
112
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

BRCA1, BRCA2 Combi

Centogene AG - the Rare Disease Company
Germany
112
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoBreast

Centogene AG - the Rare Disease Company
Germany
5828
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoColon

Centogene AG - the Rare Disease Company
Germany
6733
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoCancer

Centogene AG - the Rare Disease Company
Germany
11368
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoCancer Comprehensive

Centogene AG - the Rare Disease Company
Germany
155107
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 502

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.